Searched over 200M research papers
10 papers analyzed
These studies suggest that clinical features of emphysema include alterations in quality of life, increased exacerbations, decreased oxygen saturation, higher mortality rates, and distinct imaging and functional characteristics, often influenced by smoking, genetic factors, and coexisting conditions like pulmonary fibrosis and chronic bronchitis.
20 papers analyzed
Emphysema is a chronic lung condition characterized by the destruction of alveoli, leading to impaired respiratory function. It is often associated with chronic obstructive pulmonary disease (COPD) and can present with various clinical features depending on its severity and the presence of other conditions.
In smokers with radiological evidence of emphysema but without airway limitation, several clinical features have been identified. These patients often exhibit abnormal diffusion capacity for carbon monoxide (Dlco) values, decreased oxygen saturation during physical exertion, and a reduced quality of life as measured by the COPD assessment test (CAT). Additionally, these individuals tend to experience more frequent exacerbations and report symptoms such as chest tightness and limitations in daily activities.
The presence of interstitial features in patients with emphysema can exacerbate the severity of the disease. These patients typically show worse pulmonary function, including lower forced expiratory volume in one second (FEV1) and Dlco values, and have a shorter six-minute walk distance (6MWD). They also report higher scores on the St George's Respiratory Questionnaire (SGRQ), indicating poorer quality of life, and have increased mortality rates compared to those with emphysema alone.
Patients with combined idiopathic pulmonary fibrosis (IPF) and emphysema (CPFE) exhibit distinct clinical features. These include a higher prevalence of male gender and smoking history, more significant oxygen desaturation during rest and exercise, and higher estimated systolic pulmonary artery pressure (eSPAP). CPFE patients also have a higher fibrosis score on high-resolution CT (HRCT) scans and a lower median survival time compared to those with IPF alone. Despite these severe features, the overall mortality rate between CPFE and non-CPFE IPF patients does not significantly differ.
Familial emphysema, often associated with alpha-1-antitrypsin deficiency, presents with unique clinical features. These include an earlier onset of symptoms, a higher incidence in males, and a significant familial occurrence. Patients typically develop symptoms in their fifth or sixth decade of life, often preceded by chronic bronchitis.
The distribution of emphysema, as assessed by CT scans, correlates with various clinical features. Emphysema predominantly found in the upper and core zones is associated with lower FEV1, higher BODE index, and increased dyspnea scores. Additionally, upper-zone predominance is more common in females and is linked to higher SGRQ scores, indicating worse quality of life.
In COPD patients with a history of pulmonary tuberculosis (PTB), emphysema presents with unique characteristics. These patients often have more severe dyspnea, more frequent exacerbations, and a higher prevalence of bronchiectasis, particularly in areas affected by TB lesions. They also exhibit more severe and extensive forms of emphysema, including panlobular and centrilobular types.
Emphysema presents with a range of clinical features that vary based on its severity, distribution, and the presence of other conditions such as interstitial lung disease or previous PTB. Understanding these features is crucial for the effective management and treatment of patients with emphysema.
Most relevant research papers on this topic